Nu Skin Enterprises, Inc.

Informe acción NYSE:NUS

Capitalización de mercado: US$377.3m

Nu Skin Enterprises Dirección

Dirección controles de criterios 2/4

El CEO de Nu Skin Enterprises es Ryan Napierski , nombrado en Mar 2017, tiene una permanencia de 7.67 años. compensación anual total es $5.84M, compuesta por 17% salario y 83% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.21% de las acciones de la empresa, por valor de $790.91K. La antigüedad media del equipo directivo y de la junta directiva es de 12.1 años y 12.1 años, respectivamente.

Información clave

Ryan Napierski

Chief Executive Officer (CEO)

US$5.8m

Compensación total

Porcentaje del salario del CEO17.0%
Permanencia del CEO7.7yrs
Participación del CEO0.2%
Permanencia media de la dirección12.1yrs
Promedio de permanencia en la Junta Directiva12.1yrs

Actualizaciones recientes de la dirección

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Recent updates

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Oct 04
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18
Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Jan 18
Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Dec 14
Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nov 17
Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nu Skin: Is It Just A Growth Problem?

Oct 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Oct 09
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Sep 27
When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Sep 12

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Sep 08
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Aug 05
Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 31
Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Jun 26

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Jun 23
Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

May 22
We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

May 07
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Apr 26
Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Mar 18
Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Feb 19
Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

Feb 15

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ryan Napierski en comparación con los beneficios de Nu Skin Enterprises?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$103m

Jun 30 2024n/an/a

-US$148m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$6mUS$992k

US$9m

Sep 30 2023n/an/a

US$59m

Jun 30 2023n/an/a

US$70m

Mar 31 2023n/an/a

US$77m

Dec 31 2022US$5mUS$942k

US$105m

Sep 30 2022n/an/a

US$38m

Jun 30 2022n/an/a

US$113m

Mar 31 2022n/an/a

US$139m

Dec 31 2021US$5mUS$801k

US$147m

Sep 30 2021n/an/a

US$230m

Jun 30 2021n/an/a

US$237m

Mar 31 2021n/an/a

US$219m

Dec 31 2020US$4mUS$721k

US$191m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$146m

Mar 31 2020n/an/a

US$150m

Dec 31 2019US$2mUS$688k

US$174m

Sep 30 2019n/an/a

US$116m

Jun 30 2019n/an/a

US$125m

Mar 31 2019n/an/a

US$129m

Dec 31 2018US$3mUS$621k

US$122m

Sep 30 2018n/an/a

US$158m

Jun 30 2018n/an/a

US$146m

Mar 31 2018n/an/a

US$137m

Dec 31 2017US$3mUS$594k

US$129m

Compensación vs. Mercado: La compensación total de Ryan($USD5.84M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.18M).

Compensación vs. Ingresos: La compensación de Ryan ha aumentado mientras la empresa no es rentable.


CEO

Ryan Napierski (50 yo)

7.7yrs

Permanencia

US$5,838,579

Compensación

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Steven Lund
Co-Founder & Executive Chairman of the Board28.8yrsUS$856.61k0.24%
$ 904.8k
Ryan Napierski
President7.7yrsUS$5.84m0.21%
$ 790.9k
James Thomas
Executive VP5.3yrsUS$1.86m0.14%
$ 546.5k
Joseph Chang
Executive VP & Chief Scientific Officer18.8yrsUS$1.12m0.19%
$ 701.6k
Chayce Clark
Executive VP & General Counsel3.3yrsUS$2.28m0.32%
$ 1.2m
Steve Hatchett
Executive VP & Chief Product Officer6.8yrsUS$1.41m0.19%
$ 729.7k
Blake Roney
Founder40.8yrsUS$621.69ksin datos
Sandra Tillotson
Founder28.8yrsUS$1.06msin datos
Joe Sueper
Senior VP & CTO3.8yrssin datossin datos
Mark Adams
Chief Information Officer18.8yrssin datossin datos
Scott Pond
Vice President of Investor Relationsno datasin datossin datos
Ashok Pahwa
Chief Marketing Officer16.5yrssin datossin datos

12.1yrs

Permanencia media

66yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de NUS es experimentado (12.1 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Steven Lund
Co-Founder & Executive Chairman of the Board28.8yrsUS$856.61k0.24%
$ 904.8k
Ryan Napierski
President3.4yrsUS$5.84m0.21%
$ 790.9k
Edwina Woodbury
Independent Director9.4yrsUS$273.20k0.033%
$ 124.9k
Daniel Campbell
Lead Independent Director27.7yrsUS$280.20k0.21%
$ 802.3k
Lars Bohlin
Member of Anti-Aging Scientific Advisory Boardno datasin datossin datos
Thomas Pisano
Independent Director16.4yrsUS$257.08k0.15%
$ 547.8k
Zoe Draelos
Member of the Anti-Aging Scientific Advisory Board14.8yrssin datossin datos
Paul Cox
Member of Anti-Aging Scientific Advisory Boardno datasin datossin datos
Tomas Prolla
Member of Anti-aging Scientific Advisory Board15.1yrssin datossin datos
Zheqing Shen
Director8.3yrsUS$249.20k0.044%
$ 165.9k
Laura Nathanson
Independent Director5.4yrsUS$268.20k0.044%
$ 164.2k
Emma Battle
Independent Director3.4yrsUS$264.33k0.039%
$ 145.9k

12.1yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de NUS son experimentados ( 12.1 años antigüedad media).